Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

DLBCL · CLL · FL · MCL · WM · MZL

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Yuting Yan) · yanyuting@ihcams.ac.cn · 13820706239